[SCHEDULE 13G] VSEE HEALTH, INC. SEC Filing
Dominion-led investor group reports beneficial ownership of 1,816,389 shares of VSEE Health common stock, representing roughly 9.9% of the class. The filing covers nine reporting persons including Dominion Capital LLC, related entities and individuals Mikhail and Gennadiy Gurevich and Alon Brenner. The percentage calculations reference 16,422,690 shares outstanding as of August 27, 2025, plus 600,000 shares converted on September 3, 2025, for a total of 17,022,690 shares. The reported position includes shares issuable upon conversion of convertible notes and upon exercise of warrants held by Dominion and Ascent, each of which is subject to a 9.99% beneficial ownership limitation (the "Blocker"). The filing notes specific conversion/exercise amounts: Dominion's convertible notes convert into 1,626,022 shares and its warrants into 173,913 shares; Ascent's convertible note converts into 1,111,112 shares and its warrants into 740,741 shares. The group certifies the holdings were not acquired to change or influence control of the issuer.
Dominion-led investor group reports beneficial ownership of 1,816,389 shares of VSEE Health common stock, representing roughly 9.9% of the class. The filing covers nine reporting persons including Dominion Capital LLC, related entities and individuals Mikhail and Gennadiy Gurevich and Alon Brenner. The percentage calculations reference 16,422,690 shares outstanding as of August 27, 2025, plus 600,000 shares converted on September 3, 2025, for a total of 17,022,690 shares. The reported position includes shares issuable upon conversion of convertible notes and upon exercise of warrants held by Dominion and Ascent, each of which is subject to a 9.99% beneficial ownership limitation (the "Blocker"). The filing notes specific conversion/exercise amounts: Dominion's convertible notes convert into 1,626,022 shares and its warrants into 173,913 shares; Ascent's convertible note converts into 1,111,112 shares and its warrants into 740,741 shares. The group certifies the holdings were not acquired to change or influence control of the issuer.
Un grupo de inversionistas liderado por Dominion informa la titularidad beneficiosa de 1.816.389 acciones ordinarias de VSEE Health, aproximadamente el 9,9% de la clase. La presentación abarca a nueve personas reportantes, incluyendo Dominion Capital LLC, entidades relacionadas e individuos Mikhail y Gennadiy Gurevich y Alon Brenner. Los cálculos de porcentaje se basan en 16.422.690 acciones en circulación al 27 de agosto de 2025, más 600.000 acciones convertidas el 3 de septiembre de 2025, para un total de 17.022.690 acciones. La posición reportada incluye acciones susceptibles de convertirse a partir de notas convertibles y de ejercitar warrants poseídos por Dominion y Ascent, cada una sujeta a una limitación de propiedad beneficiosa del 9,99% (el «Bloque»). La presentación señala montos específicos de conversión/ejercicio: las notas convertibles de Dominion se convierten en 1.626.022 acciones y sus warrants en 173.913; la nota convertible de Ascent se convierte en 1.111.112 acciones y sus warrants en 740.741 acciones. El grupo certifica que las participaciones no fueron adquiridas para cambiar o influir en el control del emisor.
도미니언이 이끄는 투자자 그룹은 VSEE Health 보통주 1,816,389주에 대한 유익한 소유권을 보고했으며, 이는 전체 주식의 약 9.9%에 해당합니다. 이 서류에는 Dominion Capital LLC를 포함한 9명의 보고 대상자와 관련 법인 및 미하일·게나디 이 글레비치(Gurevich) 및 알론 브레너가 포함됩니다. 비율 계산은 2025년 8월 27일 기준 발행 주식 16,422,690주에 2025년 9월 3일에 전환된 60만 주를 더한 총 17,022,690주를 기준으로 합니다. 보고된 보유 지분에는 도미니언과 애스센트가 보유한 전환사채의 전환 주식 및 워런트 행사에 의해 발생하는 주식이 포함되며, 각각 9.99%의 유익한 소유 제한(‘차단자’)의 적용을 받습니다. 보고서는 구체적인 전환/행사 금액을 명시합니다: 도미니언의 전환사채는 1,626,022주로 전환되고 워런트는 173,913주로 전환되며; 애스센트의 전환사채는 1,111,112주로 전환되고 워런트는 740,741주로 전환됩니다. 이 그룹은 보유가 발행인의 지배권을 변경하거나 영향을 주기 위해 취득된 것이 아님을 증명합니다.
Un groupe d’investisseurs dirigé par Dominion fait état d’une détention bénéficiaire de 1 816 389 actions ordinaires de VSEE Health, soit environ 9,9 % de la catégorie. La déclaration couvre neuf personnes devant être déclarées, y compris Dominion Capital LLC, des entités affiliées et les personnes Mikhail et Gennadiy Gurevich et Alon Brenner. Les calculs de pourcentage se réfèrent à 16 422 690 actions en circulation au 27 août 2025, plus 600 000 actions converties le 3 septembre 2025, pour un total de 17 022 690 actions. La position déclarée comprend des actions susceptibles d’être obtenues par conversion de notes convertibles et par exercice d’options détenues par Dominion et Ascent, chacune étant soumise à une limite de propriété bénéficiaire de 9,99 % (le « Blocker »). La déclaration indique des montants spécifiques de conversion/exercice : les notes convertibles de Dominion se convertissent en 1 626 022 actions et ses warrants en 173 913 actions ; la note d’Ascent se convertit en 1 111 112 actions et ses warrants en 740 741 actions. Le groupe certifie que les participations n’ont pas été acquises dans le but de modifier ou d’influencer le contrôle de l’émetteur.
Eine von Dominion angeführte Investorengruppe meldet beherrschendes Eigentum an 1.816.389 VSEE Health Stammaktien, etwa 9,9% der Klasse. Die Einreichung betrifft neun meldende Personen einschließlich Dominion Capital LLC, zugehörige Einheiten und die Personen Mikhail und Gennadiy Gurevich sowie Alon Brenner. Die prozentualen Berechnungen beziehen sich auf 16.422.690 ausstehende Aktien zum 27. August 2025 zuzüglich 600.000 Aktien, die am 3. September 2025 konvertiert wurden, insgesamt 17.022.690 Aktien. Die gemeldete Position umfasst Aktien, die durch die Umwandlung von Wandelanleihen und durch Ausübung von Warrants gehalten von Dominion und Ascent zustande kommen, wobei jeweils eine 9,99%-Beteiligungslimite (der „Blocker“) gilt. Die Einreichung nennt spezifische Umwandlungs-/Ausübungsbeträge: Dominions Wandelanleihen wandeln sich in 1.626.022 Aktien um und seine Warrants in 173.913; Ascents Wandelanleihen wandeln in 1.111.112 Aktien und seine Warrants in 740.741 Aktien. Die Gruppe bestätigt, dass die Beteiligungen nicht erworben wurden, um die Kontrolle des Emittenten zu verändern oder zu beeinflussen.
مجموعة مستثمرين تقودها دومينيون تبلغ عن الملكية المفيدة لـ 1,816,389 سهماً عادية من أسهم VSEE Health، ما يعادل نحو 9.9% من الفئة. وتشمل الإحالة تسع أطراف تقارير بما في ذلك Dominion Capital LLC، والكيانات المرتبطة، والأشخاص ميخائيل وجينادي جوريفيتش وألون برنر. تستند حسابات النسبة إلى 16,422,690 سهماً قائماً حتى 27 أغسطس 2025، بالإضافة إلى 600,000 سهم تم تحويلها في 3 سبتمبر 2025، ليصبح الإجمالي 17,022,690 سهماً. تشمل الوضعية المبلغ عنها أسهماً قابلة للتحول من سندات قابلة للتحويل وممارسة أي أسهم من المنشور المملوكين من دومينيون وأ سانت وفقاً لقيود الملكية المفيدة بنسبة 9.99% (المعرّف بـ“الحاجز”). تذكر الإحالة مبالغ محددة للتحويل/الممارسة: تحويل سندات دومينيون قابلة للتحويل إلى 1,626,022 سهماً وتحويل وورنتسها إلى 173,913 سهماً؛ تحويل سند Ascent القابل للتحويل إلى 1,111,112 سهماً وورنتسها إلى 740,741 سهماً. تشهد المجموعة بأن الحيازات لم تُكتسب بهدف تغيير أو التأثير في سيطرة المصدر.
由 Dominion 主导的投资者集团报告对 VSEE Health 普通股的实益所有权为1,816,389股,约占该类股份的9.9%。 文件涉及九名申报人,包括 Dominion Capital LLC、相关实体及个人米哈伊尔·格雷维奇(Mikhail Gurevich)、根纳季·格雷维奇(Gennadiy Gurevich)和阿隆·布伦纳(Alon Brenner)。比例计算基于截至2025年8月27日在外流通股为16,422,690股,另加2025年9月3日转换的600,000股,总计17,022,690股。报告的头寸包含因 Dominion 与 Ascent 持有的可转债转换而产生的股份及行使权证所能产生的股份,每项均受9.99%的实益所有权限制(“阻挡者”)。该申报指出具体的转换/行使金额:Dominion 的可转债将转换为1,626,022股,其权证将转换为173,913股;Ascent 的可转债将转换为1,111,112股,其权证将转换为740,741股。集团证明所持股份并非为改变或影响发行人控制权而取得。
- Material stake disclosed: The group reports ownership of 1,816,389 shares, providing transparency to the market.
- Detailed conversion data provided: The filing lists convertible note and warrant conversion/exercise amounts for Dominion and Ascent, improving clarity on potential dilution.
- Use of Blocker provisions: The 9.99% beneficial ownership limitation is disclosed and was explicitly increased by notice, which limits immediate aggregation from conversions.
- Potential dilution: Convertible notes (1,626,022 and 1,111,112 shares) and warrants (173,913 and 740,741 shares) represent substantial potential issuance that could dilute existing holders if exercised beyond Blocker limits.
- Concentration of influence: Shared voting and dispositive power across affiliated entities and managers centralizes decision-making despite Schedule 13G's passive certification.
- Ambiguity in reported percentage: Cover pages show 9.9% while Item 4 references 9.99%, which may cause short-term market confusion.
Insights
TL;DR: A coordinated investor group holds a material ~9.9% stake with convertible instruments that could dilute or increase voting exposure near a 9.99% blocker.
The filing documents a meaningful economic and voting position across affiliated entities and individuals totaling 1,816,389 shares. The position is calculated using 17,022,690 shares outstanding after a recent 600,000-share conversion. Material convertible notes and warrants are included in the reported beneficial ownership but constrained by contractual 9.99% "Blocker" provisions. From a capital-structure perspective, the presence of sizeable conversion features (1.63M and 1.11M potential shares from convertible notes, plus warrants) signals potential future dilution or shifts in ownership if Blocker thresholds are adjusted or lapse. The filing's certification that securities were not acquired to change control suggests a passive posture, but the concentration and convertible exposure warrant monitoring for future exercises or amendments that could affect share supply and voting.
TL;DR: Related parties disclose shared voting and dispositive power over a near-10% position; governance implications depend on intent and future conversions.
The Schedule 13G shows shared voting and dispositive power across multiple affiliated entities and managers, which creates a consolidated influence profile despite statements of non-control. The filing explicitly identifies managerial relationships among reporting persons, which is important for assessing who may direct votes if conversions occur. The contractual 9.99% Blocker is a key governance control limiting immediate accumulation of a majority stake from conversions or exercises. Investors should note the effective increase of the Blocker to 9.99% via notices referenced in the filing; the issuer acknowledged the notices and they become effective after the specified 61-day period. This structure mitigates abrupt control shifts now but preserves pathways for material ownership changes later, depending on future actions by the group or modifications to contractual limits.
Dominion-led investor group reports beneficial ownership of 1,816,389 shares of VSEE Health common stock, representing roughly 9.9% of the class. The filing covers nine reporting persons including Dominion Capital LLC, related entities and individuals Mikhail and Gennadiy Gurevich and Alon Brenner. The percentage calculations reference 16,422,690 shares outstanding as of August 27, 2025, plus 600,000 shares converted on September 3, 2025, for a total of 17,022,690 shares. The reported position includes shares issuable upon conversion of convertible notes and upon exercise of warrants held by Dominion and Ascent, each of which is subject to a 9.99% beneficial ownership limitation (the "Blocker"). The filing notes specific conversion/exercise amounts: Dominion's convertible notes convert into 1,626,022 shares and its warrants into 173,913 shares; Ascent's convertible note converts into 1,111,112 shares and its warrants into 740,741 shares. The group certifies the holdings were not acquired to change or influence control of the issuer.
Un grupo de inversionistas liderado por Dominion informa la titularidad beneficiosa de 1.816.389 acciones ordinarias de VSEE Health, aproximadamente el 9,9% de la clase. La presentación abarca a nueve personas reportantes, incluyendo Dominion Capital LLC, entidades relacionadas e individuos Mikhail y Gennadiy Gurevich y Alon Brenner. Los cálculos de porcentaje se basan en 16.422.690 acciones en circulación al 27 de agosto de 2025, más 600.000 acciones convertidas el 3 de septiembre de 2025, para un total de 17.022.690 acciones. La posición reportada incluye acciones susceptibles de convertirse a partir de notas convertibles y de ejercitar warrants poseídos por Dominion y Ascent, cada una sujeta a una limitación de propiedad beneficiosa del 9,99% (el «Bloque»). La presentación señala montos específicos de conversión/ejercicio: las notas convertibles de Dominion se convierten en 1.626.022 acciones y sus warrants en 173.913; la nota convertible de Ascent se convierte en 1.111.112 acciones y sus warrants en 740.741 acciones. El grupo certifica que las participaciones no fueron adquiridas para cambiar o influir en el control del emisor.
도미니언이 이끄는 투자자 그룹은 VSEE Health 보통주 1,816,389주에 대한 유익한 소유권을 보고했으며, 이는 전체 주식의 약 9.9%에 해당합니다. 이 서류에는 Dominion Capital LLC를 포함한 9명의 보고 대상자와 관련 법인 및 미하일·게나디 이 글레비치(Gurevich) 및 알론 브레너가 포함됩니다. 비율 계산은 2025년 8월 27일 기준 발행 주식 16,422,690주에 2025년 9월 3일에 전환된 60만 주를 더한 총 17,022,690주를 기준으로 합니다. 보고된 보유 지분에는 도미니언과 애스센트가 보유한 전환사채의 전환 주식 및 워런트 행사에 의해 발생하는 주식이 포함되며, 각각 9.99%의 유익한 소유 제한(‘차단자’)의 적용을 받습니다. 보고서는 구체적인 전환/행사 금액을 명시합니다: 도미니언의 전환사채는 1,626,022주로 전환되고 워런트는 173,913주로 전환되며; 애스센트의 전환사채는 1,111,112주로 전환되고 워런트는 740,741주로 전환됩니다. 이 그룹은 보유가 발행인의 지배권을 변경하거나 영향을 주기 위해 취득된 것이 아님을 증명합니다.
Un groupe d’investisseurs dirigé par Dominion fait état d’une détention bénéficiaire de 1 816 389 actions ordinaires de VSEE Health, soit environ 9,9 % de la catégorie. La déclaration couvre neuf personnes devant être déclarées, y compris Dominion Capital LLC, des entités affiliées et les personnes Mikhail et Gennadiy Gurevich et Alon Brenner. Les calculs de pourcentage se réfèrent à 16 422 690 actions en circulation au 27 août 2025, plus 600 000 actions converties le 3 septembre 2025, pour un total de 17 022 690 actions. La position déclarée comprend des actions susceptibles d’être obtenues par conversion de notes convertibles et par exercice d’options détenues par Dominion et Ascent, chacune étant soumise à une limite de propriété bénéficiaire de 9,99 % (le « Blocker »). La déclaration indique des montants spécifiques de conversion/exercice : les notes convertibles de Dominion se convertissent en 1 626 022 actions et ses warrants en 173 913 actions ; la note d’Ascent se convertit en 1 111 112 actions et ses warrants en 740 741 actions. Le groupe certifie que les participations n’ont pas été acquises dans le but de modifier ou d’influencer le contrôle de l’émetteur.
Eine von Dominion angeführte Investorengruppe meldet beherrschendes Eigentum an 1.816.389 VSEE Health Stammaktien, etwa 9,9% der Klasse. Die Einreichung betrifft neun meldende Personen einschließlich Dominion Capital LLC, zugehörige Einheiten und die Personen Mikhail und Gennadiy Gurevich sowie Alon Brenner. Die prozentualen Berechnungen beziehen sich auf 16.422.690 ausstehende Aktien zum 27. August 2025 zuzüglich 600.000 Aktien, die am 3. September 2025 konvertiert wurden, insgesamt 17.022.690 Aktien. Die gemeldete Position umfasst Aktien, die durch die Umwandlung von Wandelanleihen und durch Ausübung von Warrants gehalten von Dominion und Ascent zustande kommen, wobei jeweils eine 9,99%-Beteiligungslimite (der „Blocker“) gilt. Die Einreichung nennt spezifische Umwandlungs-/Ausübungsbeträge: Dominions Wandelanleihen wandeln sich in 1.626.022 Aktien um und seine Warrants in 173.913; Ascents Wandelanleihen wandeln in 1.111.112 Aktien und seine Warrants in 740.741 Aktien. Die Gruppe bestätigt, dass die Beteiligungen nicht erworben wurden, um die Kontrolle des Emittenten zu verändern oder zu beeinflussen.